Jim Fulton focuses on representing both emerging and established technology, healthcare and biotechnology companies and the venture capital firms that invest in those companies. Concentrating in corporate and securities law, he counsels companies throughout their lifecycle on matters ranging from company formations, private financings, employee equity incentives and executive hiring, to complex spinouts, mergers and acquisitions, IPOs and SEC reporting and compliance. In the last 10 years alone, Jim has worked on more than 350 venture capital transactions, raising more than $4 billion.
Download full bio